Abstract
Background and Purpose In patients already suffering from cancer, the additional occurrence of stroke can aggravate the burden of the disease. The purpose of this study was to compare risk factors for haemorrhagic and ischemic strokes in cancer and non-cancer patients. Methods A retrospective analysis, including 1,274 stroke patients admitted to a stroke unit, was conducted from 2004 to 2007. Classical risk factors for stroke and clinical outcome measures were compared between cancer and non-cancer patients. Results Twelve percent of stroke patients had an additional diagnosis of cancer. In the non-cancer population, 84% had ischemic and 16% had haemorrhagic strokes. In cancer patients, 86% had ischemic and 14% had haemorrhagic strokes. Vascular risk factors in cancer patients, including hypertension, atrial fibrillation, coronary vessel disease, smoking, hypercholesterolemia and diabetes mellitus, showed no difference compared to the non-cancer population. Only thrombotic events occurred more often in the cancer cohort. The most frequent cancer types were urogenital, breast and gastrointestinal. Regarding clinical outcome, cancer patients had an inferior neurological condition at discharge and a trend towards a longer stay in the stroke unit. Conclusions The frequency of ischemic and haemorrhagic stroke in tumour patients is similar to that in the non-cancer population. Cerebrovascular risk factors do not significantly vary between cancer and non-cancer patients. The higher frequency of thrombotic events in cancer patients may reflect a coagulation disorder, commonly found in patients with malignancy. Clinical outcome in cancer patients may be worsened by the pre-existent co-morbidity.
Similar content being viewed by others
References
Clouston PD, DeAngelis LM, Posner JB (2006) The spectrum of neurological disease in patients with systemic cancer. Ann Neurol 31:268–273. doi:10.1002/ana.410310307
Graus F, Rogers LR, Posner JB (1985) Cerebrovascular complications in patients with cancer. Medicine (Baltimore) 64:16–35. doi:10.1097/00005792-198501000-00002
Posner JB (1995) Vascular disorders. In: Posner JB (ed) Neurologic complications of cancer. Davies, Philadelphia, pp 199–299
Lindvig K, Moller H, Mosbech J, Jensen OM (1990) The pattern of cancer in a large cohort of stroke patients. Int J Epidemiol 19:498–504. doi:10.1093/ije/19.3.498
Rogers LR (1994) Cerebrovascular complications in cancer patients. Oncology 8:23–30; Williston Park
The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators (1998) Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial. JAMA 279:1265–1272
Chaturvedi S, Ansell J, Recht L (1994) Should cerebral ischemic events in cancer patients be considered a manifestation of hypercoagulability? Stroke 25:1215–1218
Zhang YY, Cordato D, Shen Q, Sheng AZ, Hung WT, Chan DK (2006) Risk factor, pattern, etiology and outcome in ischemic stroke patients with cancer: a nested case-control study. Cerebrovasc Dis 23:181–187. doi:10.1159/000097639
Yashin AI, Ukraintseva SV, Akushevich IV, Arbeev KG, Kulminski A, Akushevich L (2008) Trade-off between cancer and aging: what role do other diseases play? Evidence from experimental and human population studies. Mech Ageing Dev :25. (Epub ahead of print)
Cestari DM, Weine DM, Panageas KS, Segal AZ, De Angelis LM (2004) Stroke in patients with cancer: incidence and aetiology. Neurology 64:2025–2030
Zhang YY, Chan DKY, Cordato D, Sheng AZ (2006) Stroke risk factor, pattern and outcome in patients with cancer. Acta Neurol Scand 114:378–383. doi:10.1111/j.1600-0404.2006.00709.x
Grisold W, Oberndorfer S, Struhal W (2009) Stroke and cancer: a review. Acta Neurol Scand 119:1–16. doi:10.1111/j.1600-0404.2008.01059.x
Kune GA, Kune S, Watson LF (2007) Colorectal cancer risk, chronic illnesses, operations and medications: case control results from the Melbourne Colorectal Cancer Study 1988. Int J Epidemiol 6:951–957. doi:10.1093/ije/dym193
Li SH, Chen WH, Tang Y, Rau KM, Chen YY, Huang TL et al (2006) Incidence of ischemic stroke post-chemotherapy: a retrospective review of 10,963 patients. Clin Neurol Neurosurg 108:150–156. doi:10.1016/j.clineuro.2005.03.008
Chan AT, Leung WT, Johnson PJ (1994) Cerebrovascular event following taxol infusion. Clin Oncol (R Coll Radiol) 6:202–203. doi:10.1016/S0936-6555(94)80062-6
Ohashi S, Yazumi S, Nishio A et al (2006) Acute cerebral infarction during combination chemotherapy with s-1 and cisplatin for a young patient with a mucin-producing adenocarcinoma of the stomach. Intern Med 45:1049–1053. doi:10.2169/internalmedicine.45.1720
Rollins N, Winick N, Bash R et al (2004) Acute methotrexate neurotoxicity: findings on diffusion-weighted imaging and correlation with clinical outcome. AJNR Am J Neuroradiol 25:1688–1695
Braithwaite RS, Chlebowski RT, Lau J, George S, Hess R, Col NF (2003) Meta-analysis of vascular and neoplastic events associated with tamoxifen. J Gen Intern Med 18:937–947. doi:10.1046/j.1525-1497.2003.20724.x
Bushnell CD, Goldstein LB (2004) Risk of ischemic stroke with tamoxifen treatment for breast cancer: a meta-analysis. Neurology 63:1230–1233
Rogers LR (2004) Cerebrovascular complications in patients with cancer. Semin Neurol 24:453–460. doi:10.1055/s-2004-861539
Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ (2007) Cancer statistics 2007. CA Cancer J Clin 57:43–66. doi:10.3322/canjclin.57.1.43
Hiatt BK, Lentz SR (2002) Prothrombotic states that predispose to stroke. Curr Treat Options Neurol 4:417–425. doi:10.1007/s11940-002-0009-1
Lee AY (2002) Cancer and thromboembolic disease: pathogenic mechanisms. Cancer Treat Rev 28:137–140. doi:10.1016/S0305-7372(02)00044-0
Rogers LR (2003) Cerebrovascular complications in cancer patients. Neurol Clin 21:167–192. doi:10.1016/S0733-8619(02)00066-X
Steiner I (1993) Nonbacterial thrombotic endocarditis-a study of 171 case reports. Cesk Patol 29:58–60
Gonzalez Quintela A, Candela MJ, Vidal C et al (1991) Non-bacterial thrombotic endocarditis in cancer patients. Acta Cardiol 46:1–9
Herrera dP, Esteban EE, Gimenez SJV, Pareja MA, Moscoso dP (2004) Nonbacterial thrombotic endocarditis as initial event of lung cancer. An Med Interna 21:495–497
Ojeda VJ, Frost F, Mastaglia FL (1985) Non-bacterial thrombotic endocarditis associated with malignant disease: a clinicopathological study of 16 cases. Med J Aust 42:629–631
Reisner SA, Brenner B, Haim N, Edoute Y, Markiewicz W (2000) Echocardiography in nonbacterial thrombotic endocarditis: from autopsy to clinical entity. J Am Soc Echocardiogr 13:876–881. doi:10.1067/mje.2000.106070
Singhal AB, Topcuoglu MA, Buonanno FS (2002) Acute ischemic stroke patterns in infective and nonbacterial thrombotic endocarditis: a diffusion-weighted magnetic resonance imaging study. Stroke 33:1267–1273. doi:10.1161/01.STR.0000015029.91577.36
Edoute Y, Haim N, Rinkevich D, Brenner B, Reisner SA (1997) Cardiac valvular vegetations in cancer patients: a prospective echocardiographic study of 200 patients. Am J Med 102:252–258. doi:10.1016/S0002-9343(96)00457-3
Daniels SK, Brailey K, Priestly DH, Herrington LR, Weisberg LA, Foundas AL (1998) Aspiration in patients with acute stroke. Arch Phys Med Rehabil 79:14–19. doi:10.1016/S0003-9993(98)90200-3
Ding R, Logemann JA (2000) Pneumonia in stroke patients: a retrospective study. Dysphagia 15:51–57
Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EEIII (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24:35–41
Quinones-Hinojosa A, Gulati M, Singh V et al (2003) Spontaneous intracerebral haemorrhage due to coagulation disorders. Neurosurg Focus 14:11. doi:10.3171/foc.2003.14.6.11
Glass J (2006) Neurologic complications of lymphoma and leukaemia. Semin Oncol 33:342–347. doi:10.1053/j.seminoncol.2006.03.004
Nguyen T, DeAngelis LM (2006) Stroke in cancer patients. Curr Neurol Neurosci Rep 6:187–191. doi:10.1007/s11910-006-0004-0
Acknowledgment
This work was supported by funding from the European Community’s Sixth Framework Programme (Contract LSSM-CT-2005-518174). It reflects only the authors’ views and the Community is not liable for any use that may be made of the information contained herein.
Author information
Authors and Affiliations
Corresponding author
Additional information
An erratum to this article can be found at http://dx.doi.org/10.1007/s11060-009-9903-7
Rights and permissions
About this article
Cite this article
Stefan, O., Vera, N., Otto, B. et al. Stroke in cancer patients: a risk factor analysis. J Neurooncol 94, 221–226 (2009). https://doi.org/10.1007/s11060-009-9818-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-009-9818-3